• EPS Innovative Medicine
  • Creating a new drug discovery platform, connecting Japan and Asia

    EPS Innovative Medicine interfaces between discovery research of new seeds by academia /bio-venture companies and markets by facilitating early launch of potential drugs.

Diverse pipeline

Diverse pipeline

EPS Innovative Medicine is engaged in discovery and development of a set of various drug candidates in pipeline to be launched into Asian and other overseas markets.

About Us

Japan-based,
globally oriented company

EPS Innovative Medicine is the first drug discovery company established to mark the 30th anniversary of EPS, a leading Japan-based contract research organization (CRO).

News

more

2022/02/07
Homepage release

Contact Us

Please feel free to contact us.